OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
73
Results
Show all
Save search
Copy query
Show results for
Unknown
(69)
Proteomics
(2)
Transcriptomics
(1)
Genomics
(1)
Organisms
Alphavirus
(2)
Anemia
(2)
Betaherpesvirinae
(2)
Borrelia
(2)
Cowpox virus
(2)
Coxsackievirus
(2)
Cytomegalovirus
(2)
Dengue virus
(2)
EFO:0001352
(2)
Filoviridae
(2)
Hepatitis B virus
(2)
Human alphaherpesvirus 1
(2)
Human betaherpesvirus 5
(2)
Human immunodeficiency virus
(2)
Human immunodeficiency virus 1
(2)
Human immunodeficiency virus 2
(2)
Influenza A virus
(2)
Influenza C virus
(2)
Japanese encephalitis virus group
(2)
Lyssavirus rabies
(2)
Middle East respiratory syndrome-related coronavirus
(2)
Nostoc sp. PCC 7120 = FACHB-418
(2)
Oropouche virus
(2)
Orthopoxvirus vaccinia
(2)
Rattus
(2)
Staphylococcus aureus
(2)
Streptococcus pneumoniae
(2)
Viruses
(2)
Cryptococcus neoformans
(1)
Homo sapiens
(1)
Repository
pride
(2)
geo
(1)
ENA
(1)
Technology Type
Bottom-up proteomics
(2)
Mass Spectrometry
(2)
Release Date
2025
(6)
2023
(6)
2019
(6)
2009
(6)
2024
(5)
2022
(5)
2018
(5)
2020
(4)
2016
(3)
2008
(3)
2007
(3)
2021
(2)
2015
(2)
2014
(2)
2010
(2)
2006
(2)
2026
(1)
2017
(1)
2012
(1)
2011
(1)
2001
(1)
1999
(1)
1998
(1)
Lab affiliation
Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA
(1)
Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil
(1)
Publication date
2026
(3)
First Public Date
2026
(1)
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
Inhibition of RhoA Prevents Cryptococcus neoformans Capsule Glucuronoxylomannan-Stimulated Brain Endothelial Barrier Disruption.
Not available
S-EPMC11481333
|
biostudies-literature
Cite
Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.
Not available
S-EPMC1951138
|
biostudies-literature
Cite
Glucuronoxylomannan from Cryptococcus neoformans down-regulates the enzyme 6-phosphofructo-1-kinase of macrophages.
Not available
S-EPMC3083223
|
biostudies-literature
Cite
Active Cryptococcus neoformans glucuronoxylomannan production prevents elimination of cryptococcal CNS infection in vivo.
Not available
S-EPMC11877788
|
biostudies-literature
Cite
Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.
Not available
S-EPMC1635532
|
biostudies-literature
Cite
A synthetic glycan array containing
Cryptococcus neoformans
glucuronoxylomannan capsular polysaccharide fragments allows the mapping of protective epitopes.
Not available
S-EPMC8163368
|
biostudies-literature
Cite
Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.
Not available
S-EPMC10171644
|
biostudies-literature
Cite
Insight into the Assembling Mechanism of
Cryptococcus
Capsular Glucuronoxylomannan Based on Molecular Dynamics Simulations.
Not available
S-EPMC7676341
|
biostudies-literature
Cite
EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.
Not available
S-EPMC3485937
|
biostudies-literature
Cite
A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.
Not available
S-EPMC5241721
|
biostudies-literature
Cite
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
